Complex probiotics for curing hypertension and coronary heart disease and preparation method thereof
A compound probiotic and coronary heart disease technology, applied in the direction of microbial-based methods, biochemical equipment and methods, and cardiovascular system diseases, can solve problems that are difficult to cure and have serious side effects, so as to prevent constipation, improve defecation, The effect of suppressing the production of carcinogens
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2009-11-18
Smart Images
Figure 1 Figure 2
Abstract
Description
Technical field
[0001] The present invention relates to a technology for improving hypertension and coronary heart disease by using compound probiotics, in particular to a compound probiotic for treating hypertension and coronary heart disease and a preparation method thereof. Ecological balance, and trigger changes in the cholesterol deployment mechanism in the human body, thereby effectively reducing the cholesterol content in the body, thereby effectively lowering blood pressure, and at the same time treating coronary heart disease. Background technique
[0002] Coronary heart disease (CHD) is caused by coronary atherosclerosis in the heart. It's the most common form of heart disease, affecting more than 7 million Americans, and what's worse, it's the leading killer of both women and men. Each year more than half a million Americans die from heart attacks caused by coronary heart disease.
[0003] Most of these deaths are preventable because CHD is lifestyle-related. T...
Examples
Embodiment 1
[0058] The compound probiotics described in the present invention are made from the strains with the following weight ratios:
[0059] The proportions of Bacillus bulgaricus, Bifidobacterium and Lactobacillus reuteri are 1, 1 and 3 respectively, and their live bacteria content is 1.8 billion / ml.
Embodiment 2
[0061] The compound probiotics described in the present invention are made from the strains with the following weight ratios:
[0062] The proportions of Bacillus bulgaricus, Bifidobacterium and Lactobacillus reuteri are 2, 1 and 4 respectively, and their live bacteria content is 2 billion / ml.
Embodiment 3
[0064] The compound probiotics described in the present invention are made from the strains with the following weight ratios:
[0065] The proportions of Bacillus bulgaricus, Bifidobacterium and Lactobacillus reuteri are 3, 2 and 5 respectively, and their live bacteria content is 2.2 billion / ml.